In a prospective cohort study of 3872 participants with CKD who were grouped by MPO levels, higher MPO levels were associated with a 10% higher risk for CKD progression (p = 0.03) compared with participants who held lower baseline MPO concentrations [201]. Here, MPO is linked to chronic kidney disease.